Nokea
A nurse is consulting a formulary about a client's new prescription for raloxifene. The nurse should identify that this medication is used to treat which of the following conditions?
- A. Osteoporosis
- B. Hypothyroidism
- C. Urinary tract infection
Correct Answer: A
Rationale: The correct answer is A: Osteoporosis. Raloxifene is a medication used to prevent and treat osteoporosis by increasing bone density. It is a selective estrogen receptor modulator that mimics estrogen's effects on bone without affecting other tissues like the uterus. This helps to reduce the risk of fractures in postmenopausal women. Choices B, C, D, E, F, and G are incorrect because raloxifene is not indicated for hypothyroidism, urinary tract infections, or any other conditions besides osteoporosis.
You may also like to solve these questions
A nurse is reviewing the medical record of a client who has sinusitis and a new prescription for cefuroxime. Which of the following client information is the priority for the nurse to report to the provider?
- A. The client has a BUN of 18 mg/dL
- B. The client takes an aspirin daily
- C. The client has a history of a severe penicillin allergy
- D. The client reports a history of nausea with cefuroxime
Correct Answer: C
Rationale: The correct answer is C: The client has a history of a severe penicillin allergy. This is the priority for the nurse to report because cefuroxime belongs to the cephalosporin class of antibiotics, which has a cross-reactivity with penicillins. Individuals with a history of severe penicillin allergy are at an increased risk of also being allergic to cephalosporins like cefuroxime. This can lead to potentially life-threatening allergic reactions. Reporting this information to the provider is crucial to avoid prescribing a medication that could harm the client.
Choice A (BUN of 18 mg/dL) is not directly related to the prescription of cefuroxime for sinusitis. Choice B (client takes an aspirin daily) is important but not as critical as the potential allergic reaction to cefuroxime. Choice D (client reports a history of nausea with cefuroxime) is relevant but does not pose an
A nurse manager is planning an in-service about pain management with opioids for clients who have cancer. Which of the following information should the nurse manager include?
- A. IM administration is recommended if PO opioids are ineffective
- B. Respiratory depression decreases as opioid tolerance develops
- C. Meperidine is the opioid of choice for treating chronic pain
- D. Withhold PRN pain medication for the client who is receiving opioids every 6 hr
Correct Answer: B
Rationale: The correct answer is B because respiratory depression decreases as opioid tolerance develops. Opioid tolerance occurs with prolonged use, leading to a decrease in the side effect of respiratory depression. This information is crucial for healthcare providers managing cancer pain with opioids. Choice A is incorrect because oral administration is preferred over intramuscular for better absorption and convenience. Choice C is incorrect as meperidine is not recommended for chronic pain due to its toxic metabolite. Choice D is incorrect as PRN pain medication should not be withheld for clients on scheduled opioid doses to ensure adequate pain control.
A nurse is assessing a client who is receiving a peripheral IV infusion and notes infiltration of fluid into the tissue surrounding the insertion site. Which of the following actions should the nurse take?
- A. Flush the IV catheter
- B. Apply pressure to the IV site
- C. Elevate the extremity
- D. Slow the infusion rate
Correct Answer: C
Rationale: The correct action is to elevate the extremity. Elevating the extremity above the level of the heart helps to reduce swelling and prevent further fluid infiltration into the surrounding tissue. This promotes proper circulation and limits potential complications. Flushing the IV catheter (choice A) would not address the infiltration issue. Applying pressure to the IV site (choice B) could cause further damage to the tissue. Slowing the infusion rate (choice D) may not be sufficient to prevent further infiltration.
Which of the following statements should the nurse include in the teaching about the new medication?
- A. You should take this medication with dairy products.
- B. This medication may cause constipation.
- C. It is common to experience headache or blurred vision while taking this medication.
- D. You should avoid the sun while taking this medication.
- E. You should use an alternate method of birth control while taking this medication.
Correct Answer: D
Rationale: The correct answer is D: You should avoid the sun while taking this medication. This is important because some medications can increase sensitivity to sunlight, leading to sunburn or skin reactions. Avoiding the sun can prevent these adverse effects.
A: You should not take this medication with dairy products as it may interfere with the absorption of the medication.
B: Constipation is a common side effect of some medications, but it is not specific to this particular medication.
C: Headache or blurred vision may occur with some medications, but it is not specific to this particular medication.
E: Using an alternate method of birth control may be necessary if the medication interferes with hormonal contraceptives, but this information is not provided in the question stem.
A nurse is preparing to administer subcutaneous heparin to a client. Which of the following should the nurse take?
- A. Massage the site after administering the medication
- B. Use a 21-gauge needle for the injection
- C. Aspirate before injecting the medication
- D. Insert the needle at least 5 cm (2 in) from the umbilicus
Correct Answer: D
Rationale: The correct answer is D: Insert the needle at least 5 cm (2 in) from the umbilicus. This is crucial to prevent any potential harm to the abdominal organs located around the umbilicus. Inserting the needle too close could lead to injury or bleeding. Massaging the site after administering (A) is not recommended as it can cause bruising or discomfort. Using a 21-gauge needle (B) is not specified for subcutaneous heparin injections. Aspirating before injecting (C) is not necessary for subcutaneous injections, as the risk of hitting a blood vessel is low.